0001214659-21-005821.txt : 20210521 0001214659-21-005821.hdr.sgml : 20210521 20210521175221 ACCESSION NUMBER: 0001214659-21-005821 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210519 FILED AS OF DATE: 20210521 DATE AS OF CHANGE: 20210521 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Weiss Patrick CENTRAL INDEX KEY: 0001755793 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38720 FILM NUMBER: 21950433 MAIL ADDRESS: STREET 1: C/O TWIST BIOSCIENCE CORPORATION STREET 2: 455 MISSION BAY BOULEVARD SOUTH CITY: SAN FRANCISCO STATE: CA ZIP: 94158 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Twist Bioscience Corp CENTRAL INDEX KEY: 0001581280 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 462058888 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 681 GATEWAY BLVD. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 800-719-0671 MAIL ADDRESS: STREET 1: 681 GATEWAY BLVD. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 marketforms-52853.xml PRIMARY DOCUMENT X0306 4 2021-05-19 0001581280 Twist Bioscience Corp TWST 0001755793 Weiss Patrick C/O TWIST BIOSCIENCE CORPORATION 681 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080 false true false false Chief Operating Officer Common Stock 2021-05-19 4 M false 2104 8.82 A 54308 D Common Stock 2021-05-19 4 M false 1974 26.66 A 56282 D Common Stock 2021-05-19 4 M false 827 25.02 A 57109 D Common Stock 2021-05-19 4 S false 4905 88.39 D 52204 D Employee Stock Option (right to buy) 8.82 2021-05-19 4 M false 2104 0 D 2027-09-28 Common Stock 2104 10521 D Employee Stock Option (right to buy) 26.66 2021-05-19 4 M false 1974 0 D 2028-11-18 Common Stock 1974 61194 D Employee Stock Option (right to buy) 25.02 2021-05-19 4 M false 827 0 D 2029-12-09 Common Stock 827 25648 D The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on December 15, 2020. The option is immediately exercisable. 10% of the shares subject to the option vested on September 28, 2017, 15% of the shares subject to the option vested on September 28, 2018, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. 20% of the shares subject to the option vested and became exercisable on October 31, 2019 and 1/60th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. 25% of the shares subject to the option vested and became exercisable on October 24, 2020 and 1/48th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. /s/ William Solis, as Attorney-in-Fact for Patrick Weiss 2021-05-21